Business
Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio
LymphaTech’s 3D Platform and Digital Capabilities to Improve Disease Identification, Accelerate Therapy Adoption, and Support Next-Generation Lymphatic TherapiesMINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that it has acquired LymphaTech Inc., for an upfront cash payment at closing of $6.8 million, plus potential
About this update from Tactile Systems Technology, Inc.
[{"type":"image","alt":"Tactile Systems Technology, Inc.","displaySize":"","headline":null,"caption":"Tactile Systems Technology, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":150,"url":"https://media.zenfs.com/en/globenewswire.com/5d5d3b18d09d63bf9ad916a0003b0c3d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/pzqO_QDvQFXBZjsCmHta1A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/5d5d3b18d09d63bf9ad916a0003b0c3d","width":300,"height":150}},"lazy":false},{"type":"text","content":"LymphaTech’s 3D Platform and Digital Capabilities to Improve Disease Identification, Accelerate Therapy Adoption, and Support Next-Generation Lymphatic Therapies","length":161,"tagName":"p"},{"type":"text","content":"MINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that it has acquired LymphaTech Inc., for an upfront cash payment at closing of $6.8 million, plus potential additional consideration that is contingent upon the achievement of future milestones.","length":426,"tagName":"p"},{"type":"text","content":"Founded in 2014, LymphaTech, Inc. is a privately held medical technology company pioneering a digital, three-dimensional (“3D”) full body measurement and monitoring platform designed specifically for lymphedema. Damage to the lymphatic system from chronic fluid accumulation can cause swelling and tissue fibrosis, significantly impacting patients’ quality of life and health care utilization. The acquisition will expand Tactile Medical’s lymphedema portfolio with new solutions that enable more accurate and efficient disease identification and progression, while broadening the Company’s research and development capabilities and strengthening its market leadership position in conditions associated with lymphatic dysfunction.","length":730,"tagName":"p"},{"type":"text","content":"LymphaTech’s primary technology is a hand-held, clinically validated solution that uses proprietary algorithms and mobile scanning to deliver highly accurate fluid volume and precise circumference measurements, two critical elements in identifying lymphedema and informing the appropriate therapy options. The platform immediatel...